← 產業報告目錄

Inhalable Biologics Market Size, Share & Trends Analysis Report By Type (Peptides And Proteins, Vaccines, Monoclonal Antibodies, RNAi-Based Therapeutics), Application (Respiratory Diseases, Diabetes, Cancer), Dosage Form (Dry Powder Inhalers, Metered Dose Inhalers, Nebulizers), And Distribution Channel (Hospital Pharmacies, Retail Pharmacies, And Online Pharmacies), By Region, And By Segment Forecasts, 2025-2034.

出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-28頁數 180報告編號 INSIGHTACE-8b290ca000

授權報價

Single User PDF$4,500 USD
Global Site License PDF$9,500 USD
洽詢購買 申請 Sample

報告摘要

The Inhalable Biologics Market on a global scale was estimated at USD 3.8 Billion in 2024 and is poised to attain USD 17.2 Billion by 2034, with a projected CAGR of 19.4% between 2025 and 2034. Inhalable Biologics encompasses biologic drugs that are breathed in and given through the lungs. The sector has gained traction as organizations seek innovative approaches to address evolving healthcare challenges. Growth is propelled by a convergence of factors: rising awareness among end users, continuous product innovation, and the mounting emphasis on efficiency and sustainability within the healthcare sector. The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion. Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, propelled by rapid industrialization and expanding end-user bases. Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing. The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global Inhalable Biologics Market Snapshot Chapter 4. Global Inhalable Biologics Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Drivers 4.3. Challenges 4.4. Trends 4.5. Investment and Funding Analysis 4.6. Porter's Five Forces Analysis 4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034 4.8. Competitive Landscape & Market Share Analysis, By Key Player (2023) 4.9. Use/impact of AI on Inhalable Biologics Market Industry Trends 4.10. Global Inhalable Biologics Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034 Chapter 5. Inhalable Biologics Market Segmentation 1: By Type, Estimates & Trend Analysis 5.1. Market Share by Type, 2024 & 2034 5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Type: 5.2.1. Peptides and Proteins 5.2.2. Vaccines 5.2.3. Monoclonal Antibodies 5.2.4. RNAi-based Therapeutics 5.2.5. Others Chapter 6. Inhalable Biologics Market Segmentation 2: By Application, Estimates & Trend Analysis 6.1. Market Share by Application, 2024 & 2034 6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application: 6.2.1. Respiratory diseases 6.2.1.1. COPD 6.2.1.2. Asthma 6.2.1.3. Cystic Fibrosis 6.2.1.4. COVID-19 6.2.1.5. Others 6.2.2. Diabetes 6.2.3. Cancer 6.2.4. Others Chapter 7. Inhalable Biologics Market Segmentation 3: By Dosage Form, Estimates & Trend Analysis 7.1. Market Share by Dosage Form, 2024 & 2034 7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Dosage Form: 7.2.1. Dry Powder Inhalers 7.2.2. Metered Dose Inhalers 7.2.3. Nebulizers 7.2.4. Others Chapter 8. Inhalable Biologics Market Segmentation 4: By Distribution Channel, Estimates & Trend Analysis 8.1. Market Share by Distribution Channel, 2024 & 2034 8.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Distribution Channel: 8.2.1. Hospital Pharmacies 8.2.2. Retail Pharmacies 8.2.3. Online Pharmacies Chapter 9. Inhalable Biologics Market Segmentation 5: Regional Estimates & Trend Analysis 9.1. Global Inhalable Biologics Market, Regional Snapshot 2024 & 2034 9.2. North America 9.2.1. North America Inhalable Biologics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034 9.2.1.1. US 9.2.1.2. Canada 9.2.2. North America Inhalable Biologics Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034 9.2.3. North America Inhalable Biologics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034 9.2.4. North America Inhalable Biologics Market Revenue (US$ Million) Estimates and Forecasts by Dosage Form, 2021-2034 9.2.5. North America Inhalable Biologics Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034 9.3. Europe 9.3.1. Europe Inhalable Biologics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034 9.3.1.1. Germany 9.3.1.2. U.K. 9.3.1.3. France 9.3.1.4. Italy 9.3.1.5. Spain 9.3.1.6. Rest of Europe 9.3.2. Europe Inhalable Biologics Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034 9.3.3. Europe Inhalable Biologics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034 9.3.4. Europe Inhalable Biologics Market Revenue (US$ Million) Estimates and Forecasts by Dosage Form, 2021-2034 9.3.5. Europe Inhalable Biologics Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034 9.4. Asia Pacific 9.4.1. Asia Pacific Inhalable Biologics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034 9.4.1.1. India 9.4.1.2. China 9.4.1.3. Japan 9.4.1.4. Australia 9.4.1.5. South Korea 9.4.1.6. Hong Kong 9.4.1.7. Southeast Asia 9.4.1.8. Rest of Asia Pacific 9.4.2. Asia Pacific Inhalable Biologics Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034 9.4.3. Asia Pacific Inhalable Biologics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034 9.4.4. Asia Pacific Inhalable Biologics Market Revenue (US$ Million) Estimates and Forecasts by Dosage Form, 2021-2034 9.4.5. Asia Pacific Inhalable Biologics Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034 9.5. Latin America 9.5.1. Latin America Inhalable Biologics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034 9.5.1.1. Brazil 9.5.1.2. Mexico 9.5.1.3. Rest of Latin America 9.5.2. Latin America Inhalable Biologics Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034 9.5.3. Latin America Inhalable Biologics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034 9.5.4. Latin America Inhalable Biologics Market Revenue (US$ Million) Estimates and Forecasts by Dosage Form, 2021-2034 9.5.5. Latin America Inhalable Biologics Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034 9.6. Middle East & Africa 9.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034 9.6.1.1. GCC Countries 9.6.1.2. Israel 9.6.1.3. South Africa 9.6.1.4. Rest of Middle East and Africa 9.6.2. Middle East & Africa Inhalable Biologics Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034 9.6.3. Middle East & Africa Inhalable Biologics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034 9.6.4. Middle East & Africa Inhalable Biologics Market Revenue (US$ Million) Estimates and Forecasts by Dosage Form, 2021-2034 9.6.5. Middle East & Africa Inhalable Biologics Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034 Chapter 10. Competitive Landscape 10.1. Major Mergers and Acquisitions/Strategic Alliances 10.2. Company Profiles 10.2.1. Kamada Pharmaceuticals 10.2.1.1. Business Overview 10.2.1.2. Key Type/Service Overview 10.2.1.3. Financial Performance 10.2.1.4. Geographical Presence 10.2.1.5. Recent Developments with Business Strategy 10.2.2. MannKind Corporation 10.2.3. Ab Initio Pharma 10.2.4. Ocugen, Inc. 10.2.5. CanSino Biologics 10.2.6. AstraZeneca

量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們